egypt
face
first
outbreak
highli
pathogen
avian
influenza
hpai
viru
detect
poultri
strategi
use
egyptian
author
mitig
reli
vaccin
poultri
depopul
infect
area
increas
awar
biosecur
level
despit
effort
viru
becom
endem
vaccineescap
variant
emerg
despit
commerci
poultri
vaccin
exhibit
protect
laboratori
set
year
egypt
laboratoryconfirm
human
case
report
countri
global
concern
regard
egyptian
influenza
virus
current
high
isol
report
possess
least
two
mutat
need
confer
ferrettoferret
airborn
transmiss
despit
mass
vaccin
program
undertaken
poultri
continu
circul
viru
result
progress
genet
evolut
signific
antigen
drift
multipl
mutat
near
major
antigen
site
date
identifi
new
clade
egyptian
clade
split
new
subclad
past
experi
egypt
prove
control
avian
influenza
poultri
primari
method
reduc
human
risk
infect
monitor
viru
evolut
extrem
import
understand
pandem
risk
pose
certain
subtyp
especi
prone
antigen
drift
mechan
evidenc
genet
antigen
diverg
hpai
virus
egypt
furthermor
highlight
prioriti
combin
vaccin
implement
specif
system
detect
earli
infect
low
pathogen
avian
influenza
lpai
virus
studi
natur
acquir
vaccineinduc
immun
avian
speci
via
appropri
diagnost
tool
serolog
surveil
recent
studi
stress
need
reinforc
serolog
test
auxiliari
tool
evalu
potenc
commerci
vaccin
monitor
vaccinedriven
evolut
emerg
variant
consequ
choic
seed
virus
clearli
recogn
inactiv
vaccin
contain
viru
belong
differ
lineag
eurasian
activ
use
order
control
hpai
outbreak
egypt
shown
earlier
studi
emerg
egypt
drift
variant
circul
one
year
later
first
outbreak
exhibit
significantli
decreas
crossreact
haemagglutin
inhibit
hi
microneutr
mn
assay
mexican
vaccin
seed
strain
evid
togeth
previou
observ
rais
import
question
mechan
antigen
drift
vaccin
pressur
addit
key
role
activ
serolog
postvaccin
surveil
assess
vaccin
efficaci
evalu
crossneutr
capabl
vaccin
concurr
increment
viru
escap
neutral
antibodi
import
current
wide
rang
serolog
assay
avail
influenza
choic
mainli
base
viral
protein
target
level
specif
requir
subtyp
specif
nonsubtyp
specif
test
laboratori
facil
need
certain
strain
despit
complex
antibodi
respons
influenza
virus
standard
serolog
test
hi
mn
routin
employ
avian
influenza
refer
laboratori
promot
faooie
network
expertis
anim
influenza
http
wwwofflunet
recent
due
wide
applic
sensit
pseudotypebas
neutral
ppnt
assay
shown
valid
altern
establish
method
studi
serolog
profil
highli
pathogen
influenza
virus
vaccineinduc
immunogen
serolog
crossreact
haemagglutinin
differ
clade
moreov
recent
studi
reveal
broadli
crossneutr
antibodi
bind
stalk
region
ha
indirectli
measur
ha
ppnt
assay
lesser
extent
mn
hi
measur
antibodi
bind
globular
head
interfer
receptor
bind
studi
report
screen
avian
sera
antibodi
elicit
lpai
hpai
virus
propos
new
perspect
widen
applic
valid
ppnt
serolog
assay
especi
potenti
streamlin
screen
larg
sampl
set
collat
infield
seroepidemiolog
studi
vaccin
programm
toward
aim
firstli
construct
ha
pseudotyp
hpai
egyptian
viru
close
relat
antigen
drift
variant
compar
serolog
framework
studi
crossstrain
immun
induc
lpai
vaccin
subsequ
studi
hapseudotyp
panel
expand
order
demonstr
uniqu
versatil
via
use
altern
report
system
reliabl
test
sera
natur
infect
bird
refer
sera
propos
power
tool
support
infield
laboratorybas
avian
serolog
lentivir
pseudotyp
ha
envelop
glycoprotein
deriv
hpai
virus
construct
describ
previous
exogen
solubl
neuraminidas
na
unitpl
sigma
ad
transfect
order
induc
releas
hapseudotyp
surfac
produc
cell
pseudotyp
produc
cotransfect
cell
complex
compris
haexpress
plasmid
pl
hiv
type
gagpol
firefli
luciferas
report
construct
pcsflw
use
fugen
roch
facilit
highli
effici
dna
transport
cell
addit
green
fluoresc
protein
gfp
pseudotyp
bear
glycoprotein
achickenegypt
strain
gener
incorpor
gfp
retrovir
construct
pcsgw
report
concurr
noha
control
gener
cotransfect
produc
cell
line
two
plasmid
gagpol
pcsflw
five
panel
sera
evalu
studi
provid
faooie
nation
refer
laboratori
newcastl
diseas
avian
influenza
istituto
zooprofilattico
dell
venezi
panel
consist
sera
posit
antibodi
lpai
vaccin
strain
obtain
chicken
vaccin
day
age
boost
week
commerci
avail
inactiv
vaccin
use
previou
studi
panel
consist
sera
posit
collect
turkey
italian
outbreak
caus
lpai
viru
panel
consist
sera
posit
stratifi
increment
hi
titer
rang
collect
chicken
vaccin
inactiv
adjuv
vaccin
use
compar
firefli
luciferas
gfppseudotyp
neutral
assay
order
test
influenza
ha
groupspecif
viru
neutral
panel
consist
refer
hyperimmun
sera
produc
influenza
subtyp
group
group
also
provid
antisera
produc
specif
pathogenfre
chicken
inocul
virus
inactiv
betapropriolacton
hpai
virus
describ
previous
panel
neg
sera
panel
confirm
agar
gel
immunodiffus
assay
agid
enzymelink
immunosorb
assay
elisa
also
employ
sera
collect
vaccin
chicken
evalu
use
standard
protocol
hi
mn
assay
use
field
strain
antigen
hi
assay
also
carri
serum
panel
use
test
antigen
homolog
mexican
lpai
vaccin
respect
standard
protocol
follow
assay
describ
previous
neg
sera
titer
assign
test
hi
assay
firefli
luciferas
pseudotyp
bear
hpai
hpai
strain
use
twofold
serial
dilut
serum
sampl
mix
equal
volum
pseudotyp
viru
result
rel
light
unit
rlu
hr
standard
condit
incub
cell
ad
well
flatbottom
cultur
plate
rlu
evalu
hr
incub
luminomet
promega
glo
max
use
brightglo
substrat
promega
measur
neutral
activ
andor
inhibitori
dose
determin
serum
dilut
result
andor
reduct
singl
round
infect
report
genemedi
signal
result
compar
control
well
contain
viru
alon
rlu
cellonli
well
subtract
read
addit
neg
sera
also
test
use
firefli
luciferas
pseudotyp
ppnt
assay
addit
perform
use
pseudotyp
bear
ha
hpai
achickenegypt
strain
use
packag
construct
gfp
report
gene
gfp
ppnt
assay
essenti
perform
describ
previous
order
determin
strain
amount
hapseudotyp
viru
requir
assay
complet
medium
dispens
well
clear
flatbottom
plate
row
serial
dilut
initi
viru
stock
prepar
follow
addit
cell
well
day
infect
gfp
express
monitor
use
fluoresc
microscopi
normal
random
field
view
use
score
overal
fraction
gfpexpress
cell
volum
hapseudotyp
viru
use
assay
calcul
choos
reciproc
pseudotyp
viru
dilut
correspond
amount
requir
transduc
cellswel
serum
neutral
activ
estim
reduct
fluoresc
express
percentag
green
cell
presenc
serum
sera
presenc
neutral
antibodi
neg
sera
defin
green
cell
high
gfp
express
estim
pseudotyp
transduct
titer
perform
use
excel
softwar
pseudotyp
titer
obtain
rang
dilut
point
express
rluml
arithmet
mean
calcul
graphpad
prism
version
graphpad
softwar
san
diego
ca
usa
statist
analys
also
undertaken
analysi
ppnt
assay
use
graphpad
ppnt
titer
normal
valu
calcul
doserespons
inhibit
analysi
order
assess
correl
ppnt
hi
mn
antibodi
titer
transform
pearson
correl
analysi
use
measur
neutral
antibodi
use
gfp
firefli
luciferas
hpai
pseudotyp
order
determin
reliabl
applic
ppnt
assay
use
differ
report
system
achickenegypt
pseudotyp
carri
gfp
test
panel
sera
posit
hi
increment
titer
rang
three
sera
score
neutral
activ
pp
titer
gfp
express
observ
sera
show
neutral
activ
test
valu
correspond
titer
around
obtain
sera
hi
titer
lower
achickenegypt
pseudotyp
similar
pattern
observ
sera
shown
complet
neutral
sera
neutral
activ
score
sera
percentag
valu
lay
order
support
quantit
result
obtain
use
gfppseudotyp
panel
sera
test
parallel
firefli
luciferas
ha
pseudotyp
ppnt
result
found
correl
strongli
hi
show
similar
neutral
profil
howev
sera
hi
titr
lower
possibl
determin
respect
ppnt
neutral
valu
pseudotyp
use
tabl
panel
sera
collect
turkey
italian
epizoot
caus
lpai
viru
test
hapseudotyp
assay
hi
use
antigen
sera
posit
hi
show
panel
differ
titer
close
correl
titer
obtain
ppnt
shown
figur
chicken
sera
confirm
ai
antibodi
free
elisa
agid
assay
also
found
neg
test
pseudotypebas
assay
order
determin
extent
hagroupspecif
heterosubtyp
crossreact
test
abil
refer
hyperimmun
avian
sera
rais
neutral
pseudotyp
produc
group
virus
belong
differ
clade
achickenegypt
group
viru
quantiti
pseudotyp
chosen
order
viru
input
around
rlu
crossneutr
activ
subtyp
determin
serum
dilut
result
reduct
luciferas
signal
sera
titer
equal
consid
crossreact
shown
figur
notabl
hainfluenza
pseudotyp
abl
detect
crossspecif
neutral
within
group
variat
observ
pseudotyp
show
similar
pattern
crossreact
group
pseudotyp
exhibit
crossreact
sera
gener
subtyp
group
pseudotyp
exhibit
crossreact
sera
gener
addit
control
pseudotyp
also
test
refer
sera
respect
order
provid
evid
crossreact
group
group
figur
three
report
avian
influenza
virus
infect
human
howev
sinc
regular
report
natur
infect
human
avian
influenza
virus
although
infect
seem
limit
littl
human
human
transmiss
potenti
emerg
viru
capabl
spread
human
popul
could
occur
via
differ
mechan
avian
human
viru
reassort
recircul
exist
subtyp
andor
gradual
adapt
anim
virus
human
transmiss
emerg
influenza
virus
highlight
abil
subtyp
mutat
low
highli
pathogen
variant
introduct
domest
poultri
follow
hpai
virus
lpai
progenitor
incid
rais
concern
potenti
pandem
caus
virus
subtyp
avian
influenza
virus
potenti
transmit
varieti
nonavian
host
includ
human
case
mutat
seem
taken
place
rapidli
introduct
wild
bird
reservoir
other
lpai
viru
circul
poultri
month
prior
mutat
factor
respons
mechan
lpai
viru
mutat
hpai
viru
remain
unclear
howev
reason
assum
wider
circul
lpai
poultri
higher
chanc
mutat
hpai
occur
recent
implement
activ
surveil
vaccin
polici
administr
appropri
vaccin
domest
poultri
facilit
erad
hpai
mani
countri
control
infect
poultri
valid
sensit
specif
assay
detect
antibodi
avian
influenza
virus
avian
nonavian
speci
repres
main
object
influenza
expert
anim
public
health
sector
measur
neutral
antibodi
respons
critic
influenza
serodiagnosi
evalu
novel
vaccin
effect
drift
variant
aris
consequ
vaccin
pressur
ppnt
assay
repres
reliabl
safe
test
determin
neutral
antibodi
respons
subtyp
influenza
virus
neutral
assay
shown
high
sensit
specif
compar
establish
serolog
test
hi
mn
demonstr
wide
applic
antivir
therapeut
antibodi
screen
evalu
vaccin
efficaci
moreov
method
togeth
use
evalu
well
circul
isol
match
ai
vaccin
formul
order
updat
vaccin
use
criteria
similar
use
human
influenza
vaccin
exploit
inher
sensit
assay
aim
studi
determin
level
antibodi
respons
pseudotyp
carri
polybas
cleavag
site
sera
obtain
avian
speci
vaccin
commerci
avail
inactiv
vaccin
use
poultri
farm
natur
infect
lpai
influenza
virus
show
correl
ppnt
classic
serolog
assay
hi
mn
panel
sera
obtain
chicken
vaccin
strain
test
previous
us
egyptian
challeng
strain
signific
differ
strain
shown
hi
mn
assay
like
due
antigen
drift
driven
implement
vaccin
poultri
parallel
pseudotyp
bear
hpai
construct
achickenegypt
titer
obtain
via
hi
mn
correl
strongli
figur
obtain
use
pseudotyp
r
r
pseudotyp
use
correl
r
despit
fact
ha
use
ppnt
assay
antigen
match
belong
differ
clade
rank
order
neutral
valu
obtain
pseudotyp
mirror
hi
mn
assay
interestingli
compar
hi
mn
ppnt
overal
give
higher
numer
titer
appear
sensit
mn
recent
studi
rais
possibl
lower
incorpor
ha
spike
retrovir
pseudotyp
compar
wildtyp
viru
make
pseudotyp
sensit
allow
bind
antibodi
antigen
site
ha
surfac
also
ha
stalk
shown
previou
studi
similar
result
obtain
control
panel
sera
posit
hi
test
ha
pseudotyp
show
presenc
neutral
antibodi
respons
hpai
sera
chicken
infect
lpai
viru
also
profil
neutral
strongli
correl
hi
ppnt
assay
potenti
use
resourcelimit
countri
costbenefit
assay
could
increas
avail
differ
report
system
exampl
use
gfp
report
instead
firefli
luciferas
addit
laboratori
lack
fluoresc
luciferas
detect
capabl
report
could
use
result
studi
reveal
neutral
profil
ppnt
use
gfp
report
show
clearli
firefli
luciferas
ppnt
titer
stratif
especi
sera
give
low
respons
hi
compar
analysi
result
obtain
use
two
differ
report
set
sera
perform
show
clear
correl
strong
neutral
profil
although
correl
protect
yet
establish
ppnt
assay
tabl
result
crossreact
analys
group
ha
influenza
pseudotyp
antisera
ha
subtyp
shed
new
light
perform
ppnt
assay
use
hi
standard
firstli
specif
gain
use
influenza
pseudotyp
consid
cutoff
neg
sera
assign
valu
equival
pseudotyp
show
degre
crossreact
sera
gener
virus
belong
ha
group
strong
reactiv
pseudotyp
test
hyperimmun
sera
shown
figur
furthermor
reactiv
observ
valid
reliabl
qualiti
oiefao
refer
sera
repres
prerequisit
improv
serodiagnosi
help
evalu
effect
vaccin
strategi
bear
mind
extens
librari
refer
sera
influenza
strain
essenti
aspect
pandem
influenza
prepared
like
new
panel
refer
sera
need
prepar
use
pseudotypebas
assay
becom
wide
use
futur
ppnt
assay
valid
surrog
complex
timeconsum
mn
hi
influenza
pseudotyp
employ
screen
antibodi
respons
particl
surfac
due
fact
ha
major
antigen
viru
neutral
antibodi
produc
permit
ha
subtyp
antigen
track
viru
evolut
help
improv
evalu
vaccin
effect
vaccin
viru
strain
select
